9th Circuit Finds Stem Cells Are Drugs Under FDCA, Reverses Lower Court
SAN FRANCISCO — A stem cell mixture used by clinics is a drug under the U.S. Federal Food, Drug, and Cosmetic Act (FDCA), the Ninth Circuit U.S. Court of Appeals ruled...To view the full article, register now.
Already a subscriber? Click here to view full article